Reaction Details Report a problem with these data
Target
Alpha-2C adrenergic receptor
Ligand
BDBM30712
Substrate
n/a
Ki
31±n/a nM
Comments
PDSP_1428
Citation
 Bylund, DB; Blaxall, HS; Iversen, LJ; Caron, MG; Lefkowitz, RJ; Lomasney, JW Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol Pharmacol 42:1-5 (1992) [PubMed] 
Target
Name:
Alpha-2C adrenergic receptor
Synonyms:
ADRA2C | adrenergic Alpha2C
Type:
Enzyme Catalytic Domain
Mol. Mass.:
27257.01
Organism:
OK
Description:
adrenergic Alpha2C ADRA2C OK::G3GWB4
Residue:
230
Sequence:
MAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSFYRRSDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQLPEPLFKFFFWIGYCKSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ
  
Inhibitor
Name:
BDBM30712
Synonyms:
6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl-phenol;hydrochloride | 6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-phenol;hydrochloride | 6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol;hydrochloride | MLS000038040 | Oxymetazoline | SMR000059324 | cid_66259
Type:
Small organic molecule
Emp. Form.:
C16H24N2O
Mol. Mass.:
260.3746
SMILES:
Cc1cc(c(O)c(C)c1CC1=NCCN1)C(C)(C)C |t:11|
Structure:
Search PDB for entries with ligand similarity: